David Karnak
Impact in
- Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 5
- Ubiquitin and proteasome pathways 4
- Glycosylation and Glycoproteins Research 3
- Cell death mechanisms and regulation 3
- Wnt/β-catenin signaling in development and cancer 3
- Cancer therapeutics and mechanisms 3
- Oncology 9
- PARP inhibition in cancer therapy 4
- Co-authors
- Theodore S. Lawrence (18 shared papers)Ben Margolis (6 shared papers)Meredith A. Morgan (10 shared papers)Liang Xu (4 shared papers)Samuel W. Straight (4 shared papers)Jonathan Maybaum (8 shared papers)Jiqin Lian (2 shared papers)Leslie A. Parsels (8 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (5 papers)Clinical Cancer Research (4 papers)Journal of Biological Chemistry (3 papers)Cancer Research (2 papers)Translational Oncology (2 papers)
- Partner nations
- United StatesChinaPoland
In The Last Decade
David Karnak
29 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 89
- Cell Biology 382
- Oncology 534
- Aging 31
- Molecular Biology 1.1k
- Cancer Research 153
Countries citing papers authored by David Karnak
This map shows the geographic impact of David Karnak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Karnak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Karnak more than expected).
Fields of papers citing papers by David Karnak
This network shows the impact of papers produced by David Karnak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Karnak. The network helps show where David Karnak may publish in the future.
Co-authors
The 25 scholars most cited alongside David Karnak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 195 | |
| 2 | 1998 | 173 | |
| 3 | 2000 | 144 | |
| 4 | 2014 | 131 | |
| 5 | 2016 | 109 | |
| 6 | 2017 | 103 | |
| 7 | 2013 | 95 | |
| 8 | 2013 | 82 | |
| 9 | 2015 | 72 | |
| 10 | 2010 | 70 | |
| 11 | 2010 | 67 | |
| 12 | 2012 | 66 | |
| 13 | 2013 | 59 | |
| 14 | 2016 | 53 | |
| 15 | 2002 | 50 | |
| 16 | 2000 | 40 | |
| 17 | 2001 | 39 | |
| 18 | 2004 | 34 | |
| 19 | 2009 | 34 | |
| 20 | 2019 | 17 |
About David Karnak
David Karnak is a scholar working on Molecular Biology, Oncology, Cell Biology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 29 papers that have together received 1.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Ubiquitin and proteasome pathways (4 papers), PARP inhibition in cancer therapy (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cell death mechanisms and regulation (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Cell Biology (382 citations), Oncology (534 citations), Aging (31 citations), Molecular Biology (1.1k citations) and Cancer Research (153 citations). David Karnak has collaborated with scholars based in United States, China and Poland. Frequent co-authors include Theodore S. Lawrence, Ben Margolis, Meredith A. Morgan, Liang Xu, Samuel W. Straight, Jonathan Maybaum, Jiqin Lian, Leslie A. Parsels, Mary A. Davis and Lili Zhao. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Clinical Cancer Research, Journal of Biological Chemistry, Cancer Research and Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.